Galangin (GLN) Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells by Targeting Skp2-Induced Epithelial–Mesenchymal Transition (EMT)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galangin (GLN) Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells by Targeting Skp2-Induced Epithelial–Mesenchymal Transition (EMT)
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 13, Issue -, Pages 9235-9244
Publisher
Informa UK Limited
Online
2020-09-17
DOI
10.2147/ott.s264209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galangin, a Flavonoid from Lesser Galangal, Induced Apoptosis via p53-Dependent Pathway in Ovarian Cancer Cells
- (2020) Haizhi Huang et al. MOLECULES
- ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse Gliomas
- (2019) Lincoln A. Edwards et al. Frontiers in Neurology
- Anti-neuroinflammatory effects of galangin in LPS-stimulated BV-2 microglia through regulation of IL-1β production and the NF-κB signaling pathways
- (2018) Mi Eun Kim et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor β-Induced Epithelial–Mesenchymal Transition
- (2018) Zhaotao Wang et al. NEUROCHEMICAL RESEARCH
- Multifunctional selenium nanoparticles with Galangin-induced HepG2 cell apoptosis through p38 and AKT signalling pathway
- (2018) Yinghua Li et al. Royal Society Open Science
- Adult Glioblastoma
- (2017) Brian M. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- Ethanolic Extract of Algerian Propolis and Galangin Decreased Murine Melanoma T
- (2016) Lamia Benguedouar et al. Anti-Cancer Agents in Medicinal Chemistry
- The antioxidant, cytotoxic, and antigenotoxic effects of galangin, puerarin, and ursolic acid in mammalian cells
- (2016) Merve Bacanlı et al. DRUG AND CHEMICAL TOXICOLOGY
- The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation
- (2016) Isabele C. Iser et al. MEDICINAL RESEARCH REVIEWS
- Galangin inhibits cell invasion by suppressing the epithelial-mesenchymal transition and inducing apoptosis in renal cell carcinoma
- (2016) JINGYI CAO et al. Molecular Medicine Reports
- Epithelial-mesenchymal transition in glioblastoma progression
- (2016) YASUO IWADATE Oncology Letters
- Galangin, a novel dietary flavonoid, attenuates metastatic feature via PKC/ERK signaling pathway in TPA-treated liver cancer HepG2 cells
- (2015) Shang-Tao Chien et al. Cancer Cell International
- Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1αsignalling
- (2015) Bo Xu et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Glioblastoma multiforme: Pathogenesis and treatment
- (2015) Constantinos Alifieris et al. PHARMACOLOGY & THERAPEUTICS
- Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis
- (2015) Haizhi Huang et al. Journal of Functional Foods
- Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
- (2014) Q Yang et al. BRITISH JOURNAL OF CANCER
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer
- (2008) Dan D. Hershko CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started